Dr. Pai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Tufts
800 Washington ST
Boston, MA 02111Phone+1 617-636-6227Fax+1 617-636-8538
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2005
Harvard Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2013 - 2026- MA State Medical License 2011 - 2024
NY State Medical License 2004 - 2012
CT State Medical License 2005 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy Start of enrollment: 2022 Jan 03
- NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer Start of enrollment: 2020 Nov 24
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 13 citationsCemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao
Journal of Clinical Oncology. 2024-03-20 - 44 citationsNeuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS databaseTakahisa Mikami, Bobby Chi-Hung Liaw, Mizuho Asada, Takahiro Niimura, Yoshito Zamami
Journal of Neuro-Oncology. 2021-01-09 - 2 citationsImmune-related adverse events in cancer patients being treated with immune checkpoint inhibitors.Margaret Byrne, Mathew Lucas, Lori Pai, Janis L. Breeze, Susan K. Parsons
European Journal of Haematology. 2021-09-03
Press Mentions
- Neuroimmunological Adverse Events Associated with Immune Checkpoint Inhibitor: A Retrospective, Pharmacovigilance Study Using FAERS DatabaseJanuary 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
